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The past few decades have seen major advances in evaluation
and treatment of fetal cardiovascular diseases. Largely due
to advances in imaging, recognition of structural pathology
in the developing human heart can now be performed as
early as the 12th week of pregnancy and can be seen to
develop and progress through gestation. Because of the
observation that serious structural congenital heart disease
may progress from seemingly minor disease if untreated,
several centers are now intervening before birth to address
such abnormalities and attempt to prevent the further
development of structural disease. Furthermore, detailed
assessment of cardiac rhythm, function, and myocardial
mechanics is now also possible as early as the ﬁrst trimester.
Transplacental treatment for fetal rhythm abnormalities has
dramatically changed the outcomes for aﬀected pregnancies
in the past decade. More recently, several centers have begun
to incorporate routine fetal cardiovascular assessment in the
evaluation of diseases such as congenital cystic adenomatiod
malformation of the lung, twin-twin transfusion syndrome,
and congenital diaphragmatic hernia where structural dis-
ease may impose signiﬁcant comorbidity postnatally, and
hemodynamic derangements and functional pathology sec-
ondary to the primary process may impact the fetus in utero.
Recognition of potentially treatable fetal cardiac disease may
alter the prognosis for these patients in the perinatal period
as in utero treatment to address the primary abnormality
has been shown to improve the hemodynamic derangements
observed.Finally,prenatalrecognitionoffetalcardiacdisease
in general may be changing the natural history and incidence
of disease in the postnatal population.
Regardless of training and background, any healthcare
professional involved in the diagnosis and management of
diseases of the fetus and newborn now needs to be cognizant
of the potential contribution of prenatal cardiac assessment
andtreatmentinthecongenitallymalformedorunwellfetus.
In this special issue on the fetus as a cardiac patient, we have
invited a few papers addressing issues unique to this patient
group.
The ﬁrst paper of this special issue addresses ethical
issues relating to fetal diagnosis of a major abnormality with
special emphasis on cardiac malformations. Presented are
discussions of the ethical concept of beneﬁcence and the
principle of patient autonomy in the context of counseling
expectant mothers and the complex ethical situation which
arises in the consideration of the fetus as a patient.
The second paper presents a comprehensive review
of cardiac ﬁndings in twin-to-twin transfusion syndrome
(TTTS),aconditionwhichisaseverecomplicationofmono-
chorionic twin pregnancy. TTTS is characterized clinically
on ultrasound by polyhydramnios in the “recipient” twin
and oligohydramnios in the “donor” with varying degrees of
cardiac dysfunction in the recipient. The pathophysiology of
the syndrome itself and of the development of cardiomyo-
pathicchangesremainsincompletelyunderstood.Thereview
discusses what is known with respect to the cardiac ﬁndings
at presentation, natural history, and response to treatment2 International Journal of Pediatrics
and discusses current approaches to a comprehensive cardiac
evaluation of aﬀected fetuses. The third paper describes a
large series of fetuses presenting with ﬁndings consistent
with cardiomyopathy or myocarditis and represents a large
natural history study of these entities, underlining the
particularly high perinatal loss rate with diagnosis of dilated
cardiomyopathy or myocarditis, as opposed to many of the
hypertrophic myopathies.
The issue concludes with two thought-provoking review
articles regarding the intrauterine environment and the
complex interaction the developing fetal brain and cir-
culatory system have with each other and the placental
circulation. In the ﬁrst of these, the authors present a
discussion of intrauterine hypoxia, its various causes, and
mechanisms whereby disease in the fetus may result. The
ﬁnal paper presents a comprehensive review of the current
understanding of pathologic ﬁndings in the developing
brain of the fetus and infant with congenital heart disease.
Methods for detection, potential etiologies, and implications
for neurodevelopmental outcome are discussed. Intriguing
speculation regarding the possibility of altering the natural
history of developmental brain abnormalities via in utero
intervention will leave the reader eagerly anticipating future
developments in the rapidly advancing ﬁeld of fetal cardio-
vascular assessment and treatment.
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